Medication info
Joylax Tablet (Acyclovir)

Joylax Tablet (Acyclovir)

Prescription medicationTabletIntravenous injection
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
The U Pharmaceutical Co., Ltd.
Appearance
Light blue round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201908117 · Approved 2019.11.27 · Insurance code 057000420

Summary

Main use
Treatment of herpes zoster; treatment and prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older
Who receives it
Adults · Children
Adult administration
1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is preferable to start treatment as soon as possible after infection. For recurrent infections, administration is recommended at the first appearance of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer this drug 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its effectiveness. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6 ~ 12 months. 3. Prevention of herpes simplex infections in patients with impaired immune function 1) Administer this drug 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer this drug 800 mg per dose 5 times daily at approximately 4-hour intervals, omitting the bedtime dose, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is preferable to start treatment as soon as possible after infection; the sooner treatment is started, the better the effect. Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; caution should be exercised, such as by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated with intravenous injection. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/min), this drug should preferably be administered at 200 mg every 12 hours. 2. Treatment of varicella-zoster virus infections 1) In patients with creatinine clearance less than 10 mL/min, this drug should preferably be administered at a reduced dose of 800 mg per dose twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL/min, this drug should preferably be administered at a reduced dose of 800 mg per dose 3 times daily, at approximately 8-hour intervals.
Child administration
Age 2 years and older: Same as for adults. Under 2 years: Administer 1/2 the adult dose. Treatment of chickenpox in children aged 2 years and older: Administer this drug 20 mg/kg body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Ingredients

Manufacturer
The U Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of herpes zoster; treatment and prevention of herpes simplex; treatment of chickenpox in children aged 2 years and older

  • Genital herpes
  • herpes simplex virus infections
  • varicella-zoster virus infections
  • acute pain
  • chickenpox
View approved original text

This medication is used to treat and prevent infections caused by the herpes simplex virus in the skin and mucous membranes, including primary and recurrent genital herpes. It is also effective in the treatment of infections caused by the varicella-zoster virus, especially for alleviating acute pain. Please note that the effectiveness for postherpetic neuralgia has not yet been proven. Additionally, it is used for treating chickenpox in children over the age of 2. Overall, it helps to treat various skin conditions caused by viral infections and improves symptoms.

How it is given

Adult administration

1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is preferable to start treatment as soon as possible after infection. For recurrent infections, administration is recommended at the first appearance of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer this drug 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its effectiveness. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6 ~ 12 months. 3. Prevention of herpes simplex infections in patients with impaired immune function 1) Administer this drug 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer this drug 800 mg per dose 5 times daily at approximately 4-hour intervals, omitting the bedtime dose, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal malabsorption. 3) It is preferable to start treatment as soon as possible after infection; the sooner treatment is started, the better the effect. Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; caution should be exercised, such as by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated with intravenous injection. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/min), this drug should preferably be administered at 200 mg every 12 hours. 2. Treatment of varicella-zoster virus infections 1) In patients with creatinine clearance less than 10 mL/min, this drug should preferably be administered at a reduced dose of 800 mg per dose twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL/min, this drug should preferably be administered at a reduced dose of 800 mg per dose 3 times daily, at approximately 8-hour intervals.

Child administration

Age 2 years and older: Same as for adults. Under 2 years: Administer 1/2 the adult dose. Treatment of chickenpox in children aged 2 years and older: Administer this drug 20 mg/kg body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Precautions

This medication should not be used by individuals who are allergic to this drug or any of its components. Patients with impaired kidney function should use this medication with special caution. Reduced kidney function may lead to increased adverse reactions in the central nervous system. Patients with liver dysfunction should also be careful in using this medication as it may worsen liver function. In young children or infants, it should only be used minimally when absolutely necessary. Elderly individuals may also experience a higher risk of side effects due to decreased kidney function. While using this drug, severe allergic reactions or shock may occur infrequently, therefore if symptoms such as low blood pressure, difficulty breathing, or tightness in the chest occur, use should be discontinued immediately, and medical treatment should be sought. Skin reactions such as rashes, fever, blisters, and hives may occur, and if these symptoms appear, the medication should be stopped and a doctor consulted. Severe skin conditions such as Stevens-Johnson syndrome or toxic epidermal necrolysis may occur rarely. It may affect the central nervous system, leading to consciousness disorders, confusion, hallucinations, seizures, drowsiness, and anxiety, especially more frequently in the elderly or individuals with weakened kidney function. Kidney issues may be indicated by symptoms such as renal failure or hematuria, proteinuria. Hematological issues such as leukopenia, anemia, and bleeding may rarely occur. Hepatitis, liver dysfunction, and jaundice may present, so liver health must be closely monitored. Gastric symptoms like gastritis, nausea, vomiting, and diarrhea may occur, and if discomfort persists, consulting a doctor is advised. Systemic symptoms like fever, muscle weakness, and headaches may appear. Muscle pain or joint pain may occur. There may be irregular heartbeats or changes in blood pressure, so caution is advised. Urinary disturbances like difficulty urinating or urinary obstruction have been reported rarely. If symptoms do not improve or worsen, it may be necessary to switch to other treatments. Treatment is most effective when started early in the appearance of symptoms, especially in the case of shingles or chickenpox, it should be administered within a certain period after symptom onset. Patients with weakened immune systems may need to consider alternative treatments, such as intravenous injections. While taking this medication, it is important to maintain adequate hydration, especially during high doses to prevent dehydration. Caution is advised when engaging in hazardous activities such as driving or operating machinery during the course of treatment, particularly for those with reduced kidney function who may experience more pronounced consciousness disorders. Drug interactions may occur when used with other medications, particularly those affecting the kidneys, so it is advisable to consult a doctor or pharmacist before combining. Pregnant women or those who may become pregnant should use this drug cautiously, and breastfeeding mothers should ideally discontinue nursing during treatment. Children and infants should only use this drug minimally when absolutely necessary, and elderly patients require adjustment in dosage and intervals due to the increased risk of side effects.

Side effects

  • Anaphylactic shock
  • anaphylactic-like reaction
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 118 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration difficulties
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • agitation
  • amnesia
  • insomnia
  • anxiety
  • soliloquy
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urine red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • soft stools
  • upper abdominal pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • indigestion
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • generalized malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • elevated blood pressure
  • decreased blood pressure
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • alopecia
  • sweating
  • hyponatremia
  • decreased serum protein
  • increased total cholesterol levels
  • increased triglyceride levels
  • elevated serum potassium levels
  • decreased serum albumin levels
  • anxiety
  • coma
  • convulsions
  • somnolence
  • confusion
  • hallucinations
  • agitation
  • epileptic seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that does not allow light to enter. Additionally, it is important to maintain a temperature between 1 degrees to 30 degrees Celsius during storage to ensure the medication's efficacy is preserved.

Appearance and packaging

Appearance

Light blue round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.